HMBD-501

· Hummingbird Bioscience

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMBD-501, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors [Phase 1, Phase 2]

See pricing